Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

"Rhoda" Actress Puts On A Brave Face

Valerie Harper, known for her role as Rhoda Morgenstern on “The Mary Tyler Moore Show” —remember those headscarves? — revealed yesterday that she had been diagnosed with terminal brain cancer. On January 15, her doctors told her that she had as little as three months left to live.

In a tear-jerker interview with People Magazine, Harper explained that she had been diagnosed after her face went numb during rehearsal. “It hit me like a sledge hammer,” she told People Magazine. “I was terrified.”

Harper also revealed that though she will undergo chemotherapy, she has come to terms with her fate. ““I have a fighting chance until I’m gone, [but] I’m well passed my expiration date already,”she said.

The Emmy-winning actress, who also starred in her own spinoff, “Rhoda,” had previously battled lung cancer in 2009.

The Emmy-winning actress, who also starred in her own spinoff, “Rhoda,” had previously battled lung cancer in 2009.

Harper’s former colleagues and friends were shocked by the revelation, People reported.

I’m absolutely devastated by this news,” said Mary Tyler Moore, 76. “Valerie has given so much joy, laughter and love to the world — I join her fans and send much love and positive thoughts to her and her family during this difficult time.”

Hollywood matriarch extraordinaire Betty White, who played Sue Ann Perkins in the 1970s classic, told the New York Post: “Here I go wheezing on at 91 years old, and this beautiful, beautiful lady is facing something far too soon. We all love her so much, and we are going to make the most of every second we can.”

But some, like Harper herself, are fighters to the end.“I have every confidence in the world that she will shock the hell out of us and survive — to keep functioning as the great talent and human that she is,” Ed Asner, who played producer Lou Grant, told the New York Post.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.